+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novartis AG - logo

Novartis is a global healthcare company based in Basel, Switzerland. They have created a patient-centered portfolio consisting of a wide range of products and treatments to address unmet medical needs. Novartis focuses its business on three leading divisions: pharmaceuticals, eye care and generics. They are expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high-quality medicines and healthcare.

From
From
Cell Therapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cell Therapy Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Secretase Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Secretase Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Regenerative Medicine Market Report 2023-2033 - Product Thumbnail Image

Regenerative Medicine Market Report 2023-2033

  • Report
  • March 2023
  • 232 Pages
  • Global
From
HPV Testing and Pap Test Global Market Report 2024 - Product Thumbnail Image

HPV Testing and Pap Test Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Sodium-glucose transporter 2 inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Sodium-glucose transporter 2 inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
From
Vaginitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Vaginitis Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 93 Pages
  • Global
From
Pulmonary Drug Delivery Systems: Technologies and Global Markets - Product Thumbnail Image

Pulmonary Drug Delivery Systems: Technologies and Global Markets

  • Report
  • November 2022
  • 148 Pages
  • Global
From
Ranibizumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Ranibizumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 150 Pages
  • Global
From
Loading Indicator